Home
JournalsCollections
For Authors For Reviewers For Editorial Board Members
Article Processing Charges Open Access
Ethics Advertising Policy
Editorial Policy Resource Center
Company Information Contact Us
Publications > Journals > Journal of Exploratory Research in Pharmacology> Article Full Text
Review Article
OPEN ACCESS

Download PDF

Self-assembled Natural Product-based Carrier-free Nanoplatforms for Efficient Bioactivity

  • Xiao-Qing Xu1,
  • Xiao Xu1,
  • Yun Wang1,
  • Zhong-Rui Li1,2,*  and
  • Chao Han1,* 
Journal of Exploratory Research in Pharmacology   2022;7(4):223-233

doi: 10.14218/JERP.2022.00050

Received:

Revised:

Accepted:

Published online:

 Author information

Citation: Xu XQ, Xu X, Wang Y, Li ZR, Han C. Self-assembled Natural Product-based Carrier-free Nanoplatforms for Efficient Bioactivity. J Explor Res Pharmacol. 2022;7(4):223-233. doi: 10.14218/JERP.2022.00050.

Abstract

Natural products featured by an abundant molecule skeleton and structural complexity exhibit extensive pharmacological or biological activities. Thus, natural active ingredients are an important source of drug research and development. However, the inherent defects, including low solubility, low bioavailability, and unacceptable off-target toxicity, affect their development into clinical drugs. Recently, carrier-free supermolecule nanodrugs have attracted considerable attention. These nanodrugs are self-assembled by pure drugs mainly through hydrophobicity, hydrogen bond, π-π stacking, and electrostatic interaction, which possess a high drug loading capability, enhanced water solubility of the drugs, and synergistic therapeutic efficacy. In this review, natural product-based carrier-free nanoplatforms with self-assembly for efficient bioactivity were examined. These self-assembled natural products included triterpenoids, alkaloids, flavonoids, and anthraquinones. Moreover, the morphology of the formed nanoplatforms could be a nanosphere, nanofiber, nanorod, or fibrillar network, and they could exhibit several bioactivities, such as antitumor, anti-inflammatory, immunoregulation, and liver protection. Briefly, we analyzed the types and sources, formation mechanism, biological activity, and mode of action of the nanomedicine, and discussed the future of this field. We believe this review would provide a landscape of natural product-based carrier-free nanoplatforms.

Keywords

Natural products, Carrier-free nanoplatforms, Supermolecule self-assembly, Triterpenoid, Alkaloid

Introduction

Natural products possess extensive pharmacological or biological activities that could be the source of drug discovery.1 Compared with synthetic small molecules, natural products have the advantage of an abundant molecule skeleton, structural complexity, and a high degree of stereochemistry. According to statistics,2,3 approximately 50% of approved drugs among 1,881 agents over nearly four decades from 1981 to 2019 have either natural products or their derivatives. Studying natural products for treating diseases in humans has also always won a significant share of Nobel Prizes4,5 and many famous drugs have been discovered in plants, including artemisinin, taxol, guanfu base A, and vincristine. Even, several natural products have been identified as effective in treating severe acute respiratory syndrome coronavirus 2.6,7 Thus, natural products offer the best chance to discover novel effective structures to cure human illnesses. However, the inherent defects of natural products affect their development into clinical drugs, possibly owing to low solubility, low bioavailability, unacceptable off-target toxicity, and a narrow therapeutic window. Therefore, it is still a major challenge to exploit natural product-based drug discovery.

Drugs or small molecules are developed to be loaded in quantities of nanocarriers to improve the therapeutic properties, which have shown great success in the field of drug delivery.8,9 The benefits of nanodrugs are owing to the range of properties and interactions that are particular to the nanoscale structure with a size of 1–1,000 nm. Nanotechnology, such as polymer colloids, liposomes, micelles, carbon material, and a metal-organic framework, has been widely used in encapsulating natural products to increase the bioavailability, targeted delivery, and controlled release.10,11 Nevertheless, most nanocarriers perhaps have the weaknesses of a low drug loading capacity, long-term materials toxicity, undesirable immune responses, and nearly all nanocarriers have no therapeutic effect. Fortunately, carrier-free supermolecule nanodrugs have been exploited in the nanodrug delivery system.12–15 These nanodrugs are self-assembled by pure drugs without any accessories, which are probably formed through non-covalent interactions, such as Van der Waals’ force, hydrophobicity, hydrogen bond, π-π stacking, and electrostatic interaction. More importantly, carrier-free nanodrugs could significantly improve the solubility and stability of drugs, and have almost non-toxicity, a high drug loading capability, and synergistic therapeutic efficacy. Additionally, carrier-free nanodrugs are deemed as promising candidates to be the next generation of drug formulations. As an emerging field, more and more natural products are being reported to form carrier-free nanostructures by self-assembly.16 Therefore, it would be essential and of great interest to summarize and discuss natural product-based carrier-free nanoplatforms with self-assembly for efficient bioactivity. In this review, the emphasis would focus on the types and sources, formation mechanism, biological activity, and mode of action (Fig. 1). Finally, we would briefly outline the current existing problems and future development of this nanomedicine field.

Representative natural products, the self-assembled nanostructures and bioactivities.
Fig. 1  Representative natural products, the self-assembled nanostructures and bioactivities.

Natural triterpenoids-based carrier-free nanoplatforms

Natural triterpenoids, widely distributed in nature, contain six isoprene units and usually exist in plants and animals in a free, ether, ester, or glycoside form.17 Researchers18,19 have recently discovered that triterpenoids act as an antitumor, antivirus, liver protector, bactericidal, anti-inflammatory, and other physiological activities, and some of them have been approved for the treatment of clinical conditions. Furthermore, with a unique stereostructure, multifunctional groups, and multi chiral centers, triterpenes are increasingly being used to assemble supramolecular gel systems that provide therapeutic or drug delivery strategies.20,21

Ursolic acid

Ursolic acid (UA), a pentacyclic triterpenoid, is found in many natural herbs and edible plants, including Cornus officinalis, Prunella vulgaris, and Ligustrum lucidum. UA has the advantages of low toxicity and high efficacy, which possesses a wide range of bioactivities, such as antitumor, anti-metastatic, anti-inflammatory, anti-angiogenic, and antidiabetic activities.22 Fan et al.23 designed a carrier-free, pure nanodrug by self-assembly of UA (Fig. 2a). The UA nanoparticles exhibited a spherical shape with a size of 150 nm, which were formed based on the electrostatic and hydrophobic interaction between the UA molecules. More importantly, the UA nanoparticles proved to inhibit tumor growth and had the ability of liver protection and immunotherapy. Next, aspirin (Asp), a famous nonsteroidal anti-inflammatory drug,24 could interact with UA to assemble Asp-UA nanoparticles.25,26 As a pH-stimuli responsive nanodrug, the Asp-UA nanoparticles could accumulate in the tumor tissues via passive targeting, and release drugs in an acidic tumor micro-environment. Thereafter, the Asp-UA nanoparticles inhibited adhesion, migration, and invasion of breast cancer cells through upregulating the expression of E-cadherin, beta-catenin (β-catenin), and PTEN proteins, and downregulating the expression of integrin α6β1, CD44, MMP-2, COX-2, EGFR, and ERK proteins. Likewise, Zhang et al.27 established a “core-shell” co-assembly carrier-free nanosystem based on UA and epigallocatechin gallate (EGCG) for hepatocellular carcinoma synergistic treatment. EGCG, the ingredient with antioxidant activity in green tea,28 was used as a “shell” to self-polymerize to form a uniform layer, which could avoid the degradation of the UA “core”. These nanodrugs showed low cytotoxicity, good biosafety, and efficient tumor accumulation. More importantly, UA not only led to tumor cell death and delivered tumor antigens, but also activated the immune system and boosted APC cell proliferation with EGCG to enhance the antitumor effect by the acquired immune cells.

Self-assembly and antibacterial activity of baicalin-berberine and wogonoside-berberine complexes.
Fig. 2  Self-assembly and antibacterial activity of baicalin-berberine and wogonoside-berberine complexes.

(a) Ursolic acid nanodrug formed by self-assembly for tumor immune therapy (Adapted from Ref. 23 with permission. Copyright © 2018 The American Chemical Society); (b) Formation mechanism by self-assembly of liquidambaric acid (Adapted from Ref. 53 with permission. Copyright © 2020 The Elsevier Publishing Group); (c) Self-assembling process of baicalin-berberine (BA-BBR) and wogonoside-berberine (WOG-BBR) and their antibacterial activity (Adapted from Ref. 66 with permission Copyright © 2019 The American Chemical Society); (d) Possible self-assembly diagram of rhein gel (Adapted from Ref. 87 with permission. Copyright © 2019 Springer Nature Publishing Group). UA, ursolic acid; BA, baicalin; BA-BBR, baicalin-berberine; BBR, berberine; WOG, wogonoside; WOG-BBR, wogonoside-berberine.

UA could also interact with indocyanine green (ICG) and lactobionic acid (LA) to self-assemble UA-ICG-LA nanoparticles.29 ICG is the only approved agent used in clinical imaging and detection,30 and LA is an asialoglycoprotein receptor.31 The UA-ICG-LA nanodrugs were capable of tumor imaging and specifically targeting the tumor tissue. In addition, the UA-ICG-LA nanodrugs with near-infrared irradiation displayed enhanced antitumor effects collaborated with photothermal therapy and photodynamic therapy. Furthermore, Jiang et al.32 developed carrier-free nanodrugs for co-delivery of UA and chemotherapeutic doxorubicin (DOX). The coassembled dual nanodrugs exhibited a spherical shape with a size of 109 nm and a pH-triggered drug release manner. Additionally, UA could sensitize DOX for the enhanced antitumor effects and therefore significantly produced the synergistic treatment of human breast cancer BT474 cells. Likewise, Bag et al.33 studied the self-assembly of UA in different liquids in detail. They discovered that UA could self-assemble into nanostructures with vesicles, tubes, fibers, and flowers in an organic and aqueous organic solvent. UA self-assemblies could be utilized for loading fluorophores and DOX. Next, a “self-contained bioactive nanocarrier” system based on UA and paclitaxel (PTX) was developed.34 UA interacted with PTX to form a high drug loading nanoparticle via a hydrophobic interaction and hydrogen bonding. UA and PTX could significantly improve the synergistic therapeutic efficacy, while the nanodrugs were capable of eliminating the toxic side effects and risk of liver damage induced by the chemotherapy agents via the upregulation of key antioxidant proteins. Guo et al.35 also developed a carrier-free theranostic nanodrug by the self-assembly of UA, PTX, and ICG on account of electrostatic, hydrophobic, and π-π stacking interactions. The UA-PTX-ICG nanoparticles exhibited long-term near-infrared fluorescence imaging, effective passive tumor targeting, and synergistic antitumor effect by chemotherapy, photodynamic therapy, and photothermal therapy. Finally, poly(ursolic acid) (PUA) was synthesized through the polycondensation of the hydroxyl group and carboxyl group of UA.36 PUA could self-assemble into the nanoparticles with PTX. The assembled nanoparticles possessed prolonged blood circulation, enhanced tumor targeting, and significant antitumor efficacy against colorectal cancer CT26 cells.

Glycyrrhizic acid

Glycyrrhizic acid (GA), separated from Glycyrrhiza uralensis, G. inflate, or G. glabra, is a triterpene saponin, which exhibits anti-inflammatory, antitumor, and other extensive biological activities.37 GA consists of a hydrophilic di-glucuronic residue and a hydrophobic triterpenoid aglycon (glycyrrhetinic acid: GLA). Such an amphiphilic structure prompted GA to have a good self-assembly capability.38 The GA molecules were forecasted to form stable aggregates with a size of about 10 nm through the simulation of molecular dynamics.39 GA aggregation could also interact with the PTX molecules at a ratio of 3:1. Next, spherical micelles were observed in the GA aqueous solution with modest anisotropy.40 The addition of metal ions affected the minimal micelle growth. In addition, Zhao et al.41 found GA formed an injectable low-molecular-weight hydrogel with nanocluster morphology in the aqueous solution. This GA hydrogel selectively inhibited the growth of gram-positive Staphylococcus aureus and had good hemocompatibility and biocompatibility with mammalian cells. GA could assemble nanomicelles with baicalein to enhance the solubility of baicalein in the aqueous solution by more than 4,500 times.42 The nanomicelles had a sustained release effect of baicalein, which was modulated by changing pH.

In terms of chemical structure, GLA was the triterpenoid aglycon of GA. GLA had a rigid, pentacyclic triterpenoid backbone with hydroxyl and carboxyl groups, and it could self-assemble thermoreversible gels with spherical and flower-like shapes consisting of fibrillar networks.43 Wu et al.44 considered GLA to form a hydrogel with a dipole-dipole interaction as the main driving force. The GLA hydrogel showed the properties of selective dye adsorption and sustainable release, which could be used in dye waste removal as an environmentally-friendly functional material and controlled drug delivery system. GLA interacted with PTX and oleanolic acid, a triterpene for treating hepatitis, to form a natural nanomedicine-cum-carrier delivery nanoplatform.45 The nanoplatform had synergistic effects on the tumor treatment and an excellent hepatoprotective effect to reduce liver damage caused by PTX.

Ginsenosides

Ginseng is one of the most popular herbs worldwide and has been demonstrated to treat hypertension, stress, and different neurological disorders.46 Ginsenoside Ro (GRo), the active ingredient of ginseng, could markedly increase the solubility of saikosaponin a (SSa), derived from Bupleurum chinense.47 At low concentrations, GRo preferentially self-assembled into the vesicles to absorb SSa into themselves. At high concentrations, SSa first self-aggregated and then interacted with GRo to form mixed vesicles. Next, interactions between ginsenoside Rb1 and Rg1 (GRb1 and GRg1) with SSa were also explored.48 GRb1 could disperse the SSa solid in water, while no significant interaction was obtained between GRg1 and SSa. Different from GRo, GRb1 and GRg1 formed spherical micelles in the aqueous medium. Compared to GRg1, GRb1 with greater sugar groups produced more binding sites with SSa, thus leading to stronger interaction. In order to expand the application of the GRo vesicles, different drug additives were examined in terms of their effect on the Ro vesicles’ solubilization.49 The hydrophobic molecules lacking hydrophilic groups (such as quercetin and coumarin) were mainly inserted in the hydrophobic layer of the GRo vesicle, while the amphipathic molecules, including the hydrophilic and hydrophobic groups (such as baicalin and SSa) were mainly located on the palisade layer of the GRo vesicle. These results were of great significance for the further development and application of ginsenosides.

Other triterpenoids

Celastrol (CST), a pentacyclic triterpenoid, exists in Tripterygium wilfordii for treatment of cancer. CST could interact with DOX to self-assemble into carrier-free nanoparticles for a synergistic antitumor.50 CST-DOX nanoparticles could inhibit a P-gp expression to overcome DOX resistance through restraining NF-κB and activating heat shock factor 1. Thereafter, nanoparticles produced a synergistic combination chemotherapy via the ROS/JNK signaling pathway in the DOX resistant cells. Dai et al.51 adopted the dissipative particle dynamics simulations method to study the micellization behavior of platycodin, which was derived from Platycodon grandiflorum. Numerous platycodin self-assemblies with spherical, ellipse, oblate, and multilamellar vesicles were observed, which had the potential to be used as biocarriers for the drug delivery. Poricoic acid A belonging to tricyclic triterpenoids and dehydrotrametenolic acid (DTA) belonging to tetracyclic triterpenoids were isolated in Poria cocos, and could self-assemble into a low molecular weight gelator, respectively.52–54 DTA nanoparticles were also assembled based on intermolecular hydrogen bonding and could penetrate the gastrointestinal tract through an apical sodium-dependent bile transporter-based intestinal transport system for effective disease treatment. Liquidambaric acid (LAA, also known as betulonic acid) is isolated from Liquidambar formosana and possesses many biological activities.55 Zhi et al.53 prepared injectable LAA gel scaffolds loaded with DOX (Fig. 2b). LAA-DOX gel not only showed controlled gelation, sustained drug release, and less toxic side effects, but also achieved the synergistic treatment of tumors. LAA could also be loaded with PTX to assemble supramolecular nanoparticles via a hydrophobic interaction and hydrogen bond.56 Except for antitumor activity, the LAA-PTX nanoparticles exhibited a series of advantages, such as excellent water solubility, efficient tumor targeting, high bioavailability, low toxicity, and biological safety. In addition, ibuprofen, the anti-inflammatory drug, was selected to be loaded on the LAA gel.57 This gel could enhance the anti-inflammatory activity of ibuprofen by about two-thirds and its treatment even achieved about 140% of the OTC drugs. Hence, LAA gel provided a useful tool for a drug delivery strategy with enhanced anti-inflammatory activity. Natural sterols are a kind of important active ingredient, which exhibit the self-assembly ability to deliver drugs.21,58 Ergosterol (Erg), β-sitosterol, and stigmasterol, the representative sterols, could self-assemble into carrier-free nanoparticles, respectively.52,54,59 The photosensitizer chlorin e6 (Ce6) was loaded on Erg to assemble Erg-Ce6 nanoparticles through π-π stacking and hydrophobic interactions for a significantly combined antitumor. The Erg-Ce6 nanoparticles improved the water solubility and stability of Ce6 and possessed an excellent tumor targeting ability. In addition, the Erg-Ce6 nanoparticles induced reactive oxygen species generation due to the photodynamic therapy of Ce6 by promoting type I photoreactions, which resulted in a significant anticancer efficiency in vitro and in vivo. Natural sterols with better biocompatibility and biodegradability were expected to develop into nanomaterials for the drug delivery in the treatment of human illness.

Natural alkaloids-based carrier-free nanoplatforms

Natural alkaloids60,61 are important nitrogen-based compounds, which are widely distributed in a large variety of plants with different genera, such as Taxux, Picea, Ephedra, Cephalotaxus, and Stephania. Alkaloids contain multiple biological activities, including antitumor, anti-inflammatory, antioxidant, and antimicrobial effects, thus making them an ideal source of drug discovery.

Berberine

Berberine (BBR) has been widely used clinically to treat bacterial diarrhea, which exists in the Chinese herb Coptidis rhizoma.62 Lei et al.63–65 found compound precipitation occurred when C. rhizoma was simultaneously decocted with another Chinese herb Scutellaria baicalensis. This compound precipitation was the complex of the intermolecular interaction between the BBR from C. rhizoma and baicalin (BA) from S. baicalensis, and exhibited a neuroprotective effect in cobalt chloride-induced PC12 cells. Furthermore, they discovered that BBR could self-assemble with BA to form carrier-free nanoparticles, and wogonoside (WOG), another active compound from S. baicalensis, assembled into nanofibers with BBR.66 The BBR-BA nanoparticles and BBR-WOG nanofibers were formed through electrostatic and hydrophobic interactions. Compared with BBR, the BBR-BA nanoparticles exhibited enhanced bacteriostatic activity against Staphylococcus aureus, whereas the BBR-WOG nanofibers showed a weaker effect (Fig. 2c). The reason was that the BBR-BA nanoparticles with the hydrophilic groups toward the outside showed a stronger affinity to the bacteria population, thereby resulting in easily permeating into the biofilm. Next, the BBR-BA nanoparticles could also be used to treat diarrhea predominant irritable bowel syndrome.67 The synergistic effect of the nanoparticles through microbiota–gut–brain axis was better rather than the simple mixing of BBR and BA, and the mechanism was concerned with the brain-gut peptides, immune inflammation, and intestinal flora. Moreover, Huang et al.68 assembled the BBR nanoparticles with cinnamic acid (CA), a representative component from Cinnamomum cassia. The BBR molecule interacted with CA to form butterfly-like one-dimensional units, and then the units assembled three-dimensional spherical particles. The BBR-CA nanostructures showed enhanced inhibitory activity on multidrug-resistant S. aureus. 3,4,5-Methoxycinnamic acid (MCA) is the derivative of CA, which is extracted from Polygala tenuifolia. MCA could also self-assemble with BBR to form nanoparticles.69 The formation of the BBR-MCA nanoparticles was mainly based on the π-π stacking interactions and intermolecular hydrogen bonds. More importantly, the BBR-MCA nanoparticles possessed inhibiting multidrug-resistant S. aureus through the binding on the surface of bacteria. Rhein (Rhe) is the active compound from Rheum palmatum and has an anthraquinone skeleton. Rhe could interact with BBR to assemble nanoparticles with Rhe acting as a stacked backbone and BBR inserting into it.70 The antimicrobial activity against S. aureus of the BBR-Rhe nanoparticles significantly increased on account of the synergistic bacteriostasis of BBR and Rhe. The assembled nanostructures resulted in the death of the bacteria by adhering to the surface of the bacteria and increasing the drug concentration around the bacteria. Aristolochic acid (AA) is an active ingredient with a phenanthrene skeleton and exists in Aristolochia debilis. AA can cause a series of side effects, such as liver cancer, AA nephropathy, and acute kidney injury, which would seriously affect the use of herbs containing AA.71 Fortunately, the BBR-based self-assemblies with AA could neutralize the acute nephrotoxicity of AA.72 The BBR-AA self-assemblies with linear heterogenous supramolecules were formed based on the electrostatic attraction and π-π stacking. The BBR-AA supramolecules could block the toxic site of AA by activating the immune system and tumorigenesis-related pathways. These findings could offer a new strategy to eliminate the toxicity problems of herbs containing AA. Additionally, Shen et al.73 synthesized a carrier-free supramolecule containing alkylated BBR (ABBR) and rhamnolipids (RHL) against Helicobacter pylori. The ABBR-RHL supramolecules with a negative charge and size of about 160 nm were derived by the electrostatic and hydrophobic interactions. More importantly, the assembled supramolecules could eradicate the H. pylori biofilms by breaking the extracellular polymeric substances. Moreover, the supramolecules inhibited adherence of the H. pylori to restrain the ability of the biofilm re-formation, which could provide a foundation for treating biofilm-related infections.

Paclitaxel

Paclitaxel (PTX), a microtubule-interfering chemotherapy agent, has been widely employed in antitumors with an extensive spectrum, such as lung, breast, and gastric cancer.74 Pei et al.75 synthesized a glutathione-responsive PTX dimer (PTX-S-PTX) and then assembled the PTX-S-PTX nanovesicles. The nanovesicles showed a high drug loading, rapid GSH responsive release, and enhanced cancer theranostic by encapsulating the fluorescent molecule ICG. BBR with a positive charge could selectively target mitochondria to kill cancer cells, of which the mechanism was different from PTX. Therefore, the GSH-responsible dual drug conjugate (BBR-S-PTX) was obtained based on BBR and PTX through a disulfide bond.76 Similarly, BBR-S-PTX could assemble into nanoparticles with a size of 165 nm, which was formed by the hydrophobic and π-π stacking interactions. The induced assembled nanoparticles enhanced the apoptosis of the cancer cells by targeting mitochondria and also exhibited better antimicrobial activity against S. aureus and E. coli. Zhang et al.77 also prepared carrier-free nanocrystal aggregates based on PTX and indomethacin (IDM; a COX-2 inhibitor). PTX-IDM assemblies with a “brick-cement” architecture possessed synergetic antitumor effects of immunotherapy and chemotherapy. Cabazitaxel (CTX), the PTX derivative, could interact with dasatinib (DAS) to form nanoassemblies.78 DAS with amphiphilicity drove the nano-assembly of the CTX-DAS nanoparticles without any exogenous excipients. The nano-assemblies exhibited 100% drug loading and aggregation-induced emission at 422 nm for tumor diagnosis. More importantly, the treatment of cancer with the CTX-DAS nanoparticles was significantly synergetic. This approach lays the groundwork for the combinatorial use of multiple drugs with different mechanisms of action.

Camptothecin and doxorubicin

Camptothecin (CPT), an isoquinoline alkaloid, is separated from Camptotheca acuminate. CPT is a broad-spectrum antitumor agent, which inhibits the DNA topoisomerase I enzyme to lead to DNA double-stranded breaks.79 CPT was used to construct self-defensive nanostructures with the C-D-E rings of the planar construction.80 10-Hydroxycamptothecin (HCPT) with modification of hydroxyl on C-10 and carboxylic camptothecin with esterification of C-20 could also self-assemble into nanoparticles. However, due to the different molecular structures, CPT and HCPT were nanoribbons, and carboxylic CPT nanostructures were cylindric nanorods. Moreover, CPT-based assemblies could protect CPT from hydrolysis to enhance tumor therapy. Liang et al.81,82 prepared carrier-free HCPT-DOX nanoparticles formulated by simple physical self-assembling HTCP and DOX. The HCPT uptake was improved by the CPT-DOX nanoparticles with a spherical morphology and positive charge. As expected, the nanoparticles exhibited enhanced a synergistic antitumor against the cancer cells. On the other hand, the HCPT-DOX nanoparticles enhanced the antitumor in drug-resistant cancer cells. Nanosizing of HCPT and DOX showed a synergistic effect to improve the intracellular drug retention through inhibiting the P-gp efflux. Curcumin is a diarylheptanoid that exists in Curcuma longa, of which the structure is in enol-keto tautomeric equilibria with different chemical environments.83 To achieve a better-targeted drug delivery, carrier-free nanostructures with self-assembling curcumin and CPT derivatives were constructed based on the molecular structures.84 These nanoparticles with a stabilized size of 100 nm showed changeable surface charges of −10 mV with pH=7.4 and +40 mV in acidic environments. Additionally, the assembled nanoparticles showed the synergetic treatment of colorectal cancer with better lung and gallbladder targeting and macrophage-clearance escape. Likewise, Li et al.85 synthesized a DOX dimer via a pH-triggered carbamate linker and then prepared carrier-free DOX conjugated nanoparticles. The conjugated nanoparticles exhibited a concentration-dependent acid-responsive drug release and enhanced antitumor efficacy, which provided a promising method for overcoming the multidrug resistance of the cancer cells and prevented tumor recurrence. In order to improve tumor drug delivery, a simple nanotransformer (DTIG) was utilized by assembling DOX, tannic acid, and ICG.86 DTIG with hydrophilic particles exhibited prolonged blood circulation time, while DTIG became hydrophobic particles to be efficiently endocytosed by the tumor cells in the acidic micro-environment. These efficient instantaneous transformations promoted the lysosome escape of the drug and drugs release. Therefore, DTIG provided some references to the drug delivery process for cancer treatment.

Other natural product-based carrier-free nanoplatforms

Zheng et al.87 successfully prepared rhein hydrogels through intermolecular π-π interactions and hydrogen bonds (Fig. 2d). Rhein hydrogels with a nanofiber network structure exerted better anti-neuroinflammation. Furthermore, the hydrogels could improve an intracellular drug uptake by binding and recognizing toll-like receptor 4, and thereby achieve optimal anti-inflammation by inhibiting a TLR4/NFκB signaling pathway. Moreover, Liu et al.88 obtained robust nanoparticles by efficiently assembling ferric ion (Fe3+) and luteolin, a natural flavonoid molecule. These nanoparticles could notably improve the solubility and stability of luteolin. In addition, the assembled nanoparticles broadened the absorption spectrum to the near-infrared region to produce a supramolecular photothermal effect, and the coordination assembly greatly enhanced the treatment of cancer through chemotherapeutic and photothermal effects. Retinoic hydroxamic acid (RHA) contained a hydrophobic all-trans retinoic acid backbone and a hydrosoluble hydroxamic group, of which the amphiphilic groups could induce the formation of nanoparticles by self-assembly.89 Consequently, the RHA nanoparticles could result in tumor cell cycle arrest and apoptosis through inhibiting histone deacetylase and activating retinoic acid receptors. Thus, the RHA nanoparticles exhibited long-term anticancer effects with low toxicity, which could be a promising drug for melanoma therapy.

Future directions

In the field of nanobiology, natural product-based carrier-free nanoplatforms with self-assembly offer significant possibilities for drug research and development. The assembled nanodrugs have been extensively applied in targeted therapy, synergistic treatment, and theranostics. Their significant advantages include simple and “green” preparation methods, a high drug loading capacity, efficient accumulation of drugs, and effective co-delivery behavior, making them promising nanomedicine as a treatment strategy. Nevertheless, some drawbacks and challenges of carrier-free nanoplatforms still need to be solved. Self-assembled nanodrugs are slightly unstable, and it would be essential to embellish stabilizers on the surface of the nanodrugs to enhance the stability. In addition, the formation mechanism is still unclear. As such, it is confusing which kinds of natural products could self-assemble, and this should require preliminary experiments and lack basic empirical conclusions. In particular, it is difficult to precisely control the ratio of the natural products during self-assembly. Finally, the immunity function limited the therapeutic effect of the carrier-free nanodrugs. Thus, this is still a challenge for the research and development of natural product-based carrier-free nanoparticles.

Conclusions

In this review, we examined natural product-based carrier-free nanoplatforms with self-assembly for efficient bioactivity (Table 1 and Fig. 3).23,25-27,29,32-35,39,41-45,47–50,52–54,56-59,63–66,68-70,72,77,78,81,82,84,86-88 Triterpenoids with a rigid skeleton structure and high degree of stereochemistry could self-assemble into organogels by themselves. These organogels could be formed into a nanosphere, nanofiber, nanorod, or fibrillar network through hydrophobicity, π-π stacking, hydrogen bond, and electrostatic interaction. Furthermore, the gels could be used to deliver drugs or fluorescent molecules, which would exhibit various physiological activities, such as antitumor, anti-inflammatory, immunoregulation, and liver protection. Berberine was an isoquinoline alkaloid with a positive charge, and thus it could interact with natural products containing the carboxyl group. Berberine-based nanostructures were mainly governed by electrostatic and hydrophobic interactions, and displayed good bacteriostatic activity. Next, the three clinical anticancer drugs (doxorubicin, paclitaxel, and 10-hydroxycamptothecin) could also self-assemble into nanoparticles with other small molecules mainly through hydrophobic interactions, and exhibit enhanced treatment of cancer. Therefore, this review provided a reference for the design of self-assemblies between natural products.

Table 1

Natural products-based carrier-free nanoplatforms with self-assembly

Molecule 1Molecule 2MorphologyInteraction force of self-assemblyBioactivityReferences
Ursolic acid–NanosphereHydrophobic interactions/Hydrogen bondAntitumor23
AspirinNanosphereAntitumor metastasis25,26
Epigallocatechin gallateNanosphereAntitumor27
Indocyanine green and lactobionic acidNanosphereπ-π stacking/hydrophobic interaction/electrostatic interactionAntitumor29
DoxorubicinNanosphereAntitumor32,33
PaclitaxelNanosphereAntitumor34,35
Glycyrrhizic acid–NanosphereHydrophobic interactions/Hydrogen bondAntibacterial activity39,41
BaicaleinNanosphere–42
Glycyrrhetinic acid–Nanogels with fibrillar networks–43,44
Oleanolic acid and paclitaxelNanosphereAntitumor45
Ginsenoside RoSaikosaponin aNanosphereHydrogen bond/Dipolar interaction–47–49
CelastrolDoxorubicinNanosphereHydrophobic interactions/Electrostatic adherence/π-π stackingAntitumor50
Dehydrotrametenolic acidPaclitaxelNanosphereHydrogen bond/π-π stackingAntitumor52–54
Liquidambaric acidPaclitaxel or doxorubicinNetwork nanofiberAntitumor56,57
IbuprofenNetwork nanofiberAnti-inflammatory58
ErgosterolChlorin e6NanorodAntitumor52,54,59
BerberineBaicalinNanosphereElectrostatic interaction/Hydrophobic interaction/π-π stackingAntibacterial activity63–66
WogonosideNanofiberAntibacterial activity66
Cinnamic acidNanosphereAntibacterial activity68
3,4,5-Methoxycinnamic acidNanosphereAntibacterial activity69
RheinNanosphereAntibacterial activity70
Aristolochic acidLinear SupramoleculeNeutralizing nephrotoxicity72
PaclitaxelIndomethacinNanocrystalHydrophobic interaction/π-π stackingAntitumor77
CabazitaxelDasatinibNanosphereHydrogen bond/π-π stacking/van der Waals interactionAntitumor78
10-HydroxycamptothecinDoxorubicinNanorodHydrophobic interaction/π-π stackingAntitumor81,82
CamptothecinCurcuminNanosphereHydrophobic interaction/Hydrogen bond/π-π stackingAntitumor84
DoxorubicinIndocyanine green and tannic acidNanosphereπ-π stacking/Electronic interactionAntitumor86
Rhein–Nanofiberπ-π stacking/Hydrogen bondAnti-inflammatory87
LuteolinFerric ionNanosphereCoordinationinteraction/van der Waals interactionAntitumor88

– Not applicable.

Representative chemical structures of the natural products, including ursolic acid, glycyrrhizic acid, glycyrrhetic acid, oleanolic acid, celastrol, liquidambaric acid, ergosterol, berberine, camptothecin, paclitaxel, baicalein, wogonoside, luteolin, aristolochic acid, curcumin, cinnamic acid, and rhein.
Fig. 3  Representative chemical structures of the natural products, including ursolic acid, glycyrrhizic acid, glycyrrhetic acid, oleanolic acid, celastrol, liquidambaric acid, ergosterol, berberine, camptothecin, paclitaxel, baicalein, wogonoside, luteolin, aristolochic acid, curcumin, cinnamic acid, and rhein.

Abbreviations

AA: 

aristolochic acid

ABBR: 

alkylated berberine

Asp: 

aspirin

BA: 

baicalin

BBR: 

berberine

CA: 

cinnamic acid

Ce6: 

chlorin e6

CPT: 

camptothecin

CST: 

celastrol

CTX: 

cabazitaxel

DAS: 

dasatinib

DOX: 

doxorubicin

DTA: 

dehydrotrametenolic acid

EGCG: 

epigallocatechin gallate

Erg: 

ergosterol

GA: 

glycyrrhizic acid

GLA: 

glycyrrhetinic acid

GRb1: 

ginsenoside Rb1

GRg1: 

ginsenoside Rg1

GRo: 

ginsenoside Ro

HCPT: 

10-hydroxycamptothecin

ICG: 

indocyanine green

IDM: 

indomethacin

LA: 

lactobionic acid

LAA: 

liquidambaric acid

MCA: 

3,4,5-methoxycinnamic acid

PTX: 

paclitaxel

PUA: 

poly (ursolic acid)

RHA: 

retinoic hydroxamic acid

Rhe: 

rhein

RHL: 

rhamnolipids

SSa: 

saikosaponin a

UA: 

ursolic acid

WOG: 

wogonoside

Declarations

Acknowledgement

We thank Md Abdullah Al Mamun from the School of Pharmaceutical Sciences, Zhengzhou University, for English language editing assistance.

Funding

This work was co-supported by the Fundamental Research Funds for the Central Universities (2632021ZD24), the China Postdoctoral Science Foundation (2021M691647), and the Open Project of State Key Laboratory of Natural Medicines (SKLNMKF202207).

Conflict of interest

The authors have no conflicts of interest related to this publication.

Authors’ contributions

Conceptualization (ZL and CH), writing-original draft preparation (XQX, XX and YW), writing-review and editing (CH), and supervision and funding acquisition (ZL and CH). All authors read and agreed to the published version of the manuscript.

References

  1. Li H, Wei W, Xu H. Drug discovery is an eternal challenge for the biomedical sciences. Acta Materia Medica 2022;1:1-3 View Article PubMed/NCBI
  2. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod 2020;83(3):770-803 View Article PubMed/NCBI
  3. Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT, International Natural Product Sciences Taskforce. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 2021;20(3):200-216 View Article PubMed/NCBI
  4. Shen B. A new golden age of natural products drug discovery. Cell 2015;163(6):1297-1300 View Article PubMed/NCBI
  5. Efferth T, Zacchino S, Georgiev MI, Liu L, Wagner H, Panossian A. Nobel Prize for artemisinin brings phytotherapy into the spotlight. Phytomedicine 2015;22(13):A1-A3 View Article PubMed/NCBI
  6. Boozari M, Hosseinzadeh H. Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies. Phytother Res 2021;35(2):864-876 View Article PubMed/NCBI
  7. Antonio ADS, Wiedemann LSM, Veiga-Junior VF. Natural products’ role against COVID-19. RSC Adv 2020;10(39):23379-23393 View Article PubMed/NCBI
  8. Moradi Kashkooli F, Soltani M, Souri M. Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies. J Control Release 2020;327:316-349 View Article PubMed/NCBI
  9. Mishra V, Bansal KK, Verma A, Yadav N, Thakur S, Sudhakar K, et al. Solid lipid nanoparticles: emerging colloidal nano drug delivery systems. Pharmaceutics 2018;10(4):E191 View Article PubMed/NCBI
  10. Zhang R, Liu F, Tian Y, Cao W, Wang R. Editorial: Nanotechnology in traditional medicines and natural products. Front Chem 2021;9:633419 View Article PubMed/NCBI
  11. Watkins R, Wu L, Zhang C, Davis RM, Xu B. Natural product-based nanomedicine: recent advances and issues. Int J Nanomedicine 2015;10:6055-6074 View Article PubMed/NCBI
  12. Fu S, Li G, Zang W, Zhou X, Shi K, Zhai Y. Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy. Acta Pharm Sin B 2022;12(1):92-106 View Article PubMed/NCBI
  13. Huang L, Zhao S, Fang F, Xu T, Lan M, Zhang J. Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy. Biomaterials 2021;268:120557 View Article PubMed/NCBI
  14. Karaosmanoglu S, Zhou M, Shi B, Zhang X, Williams GR, Chen X. Carrier-free nanodrugs for safe and effective cancer treatment. J Control Release 2021;329:805-832 View Article PubMed/NCBI
  15. Yang MY, Zhao RR, Fang YF, Jiang JL, Yuan XT, Shao JW. Carrier-free nanodrug: A novel strategy of cancer diagnosis and synergistic therapy. Int J Pharm 2019;570:118663 View Article PubMed/NCBI
  16. Jiang S, Fu Y, Zhang X, Yu T, Lu B, Du J. Research progress of carrier-free antitumor nanoparticles based on phytochemicals. Front Bioeng Biotechnol 2021;9:799806 View Article PubMed/NCBI
  17. Biswas T, Dwivedi UN. Plant triterpenoid saponins: biosynthesis, in vitro production, and pharmacological relevance. Protoplasma 2019;256(6):1463-1486 View Article PubMed/NCBI
  18. Salvador JAR, Leal AS, Valdeira AS, Gonçalves BMF, Alho DPS, Figueiredo SAC, et al. Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment. Eur J Med Chem 2017;142:95-130 View Article PubMed/NCBI
  19. Gauthier C, Legault J, Piochon-Gauthier M, Pichette A. Advances in the synthesis and pharmacological activity of lupane-type triterpenoid saponins. Phytochem Rev 2011;10:521-544 View Article PubMed/NCBI
  20. Malík M, Velechovský J, Tlustoš P. Natural pentacyclic triterpenoid acids potentially useful as biocompatible nanocarriers. Fitoterapia 2021;151:104845 View Article PubMed/NCBI
  21. Bag BG, Majumdar R. Self-assembly of renewable nano-sized triterpenoids. Chem Rec 2017;17(9):841-873 View Article PubMed/NCBI
  22. Mlala S, Oyedeji AO, Gondwe M, Oyedeji OO. Ursolic acid and its derivatives as bioactive agents. Molecules 2019;24(15):E2751 View Article PubMed/NCBI
  23. Fan L, Zhang B, Xu A, Shen Z, Guo Y, Zhao R, et al. Carrier-Free, Pure nanodrug formed by the self-assembly of an anticancer drug for cancer immune therapy. Mol Pharm 2018;15(6):2466-2478 View Article PubMed/NCBI
  24. Patrono C, Baigent C. Role of aspirin in primary prevention of cardiovascular disease. Nat Rev Cardiol 2019;16(11):675-686 View Article PubMed/NCBI
  25. Li C, Lin J, Wu P, Zhao R, Zou J, Zhou M, et al. Small molecule nanodrug assembled of dual-anticancer drug conjugate for synergetic cancer metastasis therapy. Bioconjug Chem 2018;29(10):3495-3502 View Article PubMed/NCBI
  26. Tang Q, Liu Y, Li T, Yang X, Zheng G, Chen H, et al. A novel co-drug of aspirin and ursolic acid interrupts adhesion, invasion and migration of cancer cells to vascular endothelium via regulating EMT and EGFR-mediated signaling pathways: multiple targets for cancer metastasis prevention and treatment. Oncotarget 2016;7(45):73114-73129 View Article PubMed/NCBI
  27. Zhang B, Jiang J, Wu P, Zou J, Le J, Lin J, et al. A smart dual-drug nanosystem based on co-assembly of plant and food-derived natural products for synergistic HCC immunotherapy. Acta Pharm Sin B 2021;11(1):246-257 View Article PubMed/NCBI
  28. Legeay S, Rodier M, Fillon L, Faure S, Clere N. Epigallocatechin gallate: a review of its beneficial properties to prevent metabolic syndrome. Nutrients 2015;7(7):5443-5468 View Article PubMed/NCBI
  29. Zhao R, Zheng G, Fan L, Shen Z, Jiang K, Guo Y, et al. Carrier-free nanodrug by co-assembly of chemotherapeutic agent and photosensitizer for cancer imaging and chemo-photo combination therapy. Acta Biomater 2018;70:197-210 View Article PubMed/NCBI
  30. Reinhart MB, Huntington CR, Blair LJ, Heniford BT, Augenstein VA. Indocyanine green: historical context, current applications, and future considerations. Surg Innov 2016;23(2):166-175 View Article PubMed/NCBI
  31. Warrier DU, Dhanabalan AK, Krishnasamy G, Kolge H, Ghormade V, Gupta CR, et al. Novel derivatives of arabinogalactan, pullulan & lactobionic acid for targeting asialoglycoprotein receptor: Biomolecular interaction, synthesis & evaluation. Int J Biol Macromol 2022;207:683-699 View Article PubMed/NCBI
  32. Jiang K, Han L, Guo Y, Zheng G, Fan L, Shen Z, et al. A carrier-free dual-drug nanodelivery system functionalized with aptamer specific targeting HER2-overexpressing cancer cells. J Mater Chem B 2017;5(46):9121-9129 View Article PubMed/NCBI
  33. Bag BG, Das S, Hasan SN, Barai AC. Nanoarchitectures by hierarchical self-assembly of ursolic acid: entrapment and release of fluorophores including anticancer drug doxorubicin. RSC Adv 2017;7:18136-18143 View Article PubMed/NCBI
  34. Wang J, Zhao H, Zhi K, Yang X. Exploration of the natural active small-molecule drug-loading process and highly efficient synergistic antitumor efficacy. ACS Appl Mater Interfaces 2020;12(6):6827-6839 View Article PubMed/NCBI
  35. Guo Y, Jiang K, Shen Z, Zheng G, Fan L, Zhao R, et al. A small molecule nanodrug by self-assembly of dual anticancer drugs and photosensitizer for synergistic near-infrared cancer theranostics. ACS Appl Mater Interfaces 2017;9(50):43508-43519 View Article PubMed/NCBI
  36. Ou K, Xu X, Guan S, Zhang R, Zhang X, Kang Y, et al. Nanodrug carrier based on poly(ursolic acid) with self-anticancer activity against colorectal cancer. Adv Funct Mater 2020;30:1907857 View Article PubMed/NCBI
  37. Wang L, Yang R, Yuan B, Liu Y, Liu C. The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb. Acta Pharm Sin B 2015;5(4):310-315 View Article PubMed/NCBI
  38. Selyutina OY, Polyakov NE. Glycyrrhizic acid as a multifunctional drug carrier - From physicochemical properties to biomedical applications: A modern insight on the ancient drug. Int J Pharm 2019;559:271-279 View Article PubMed/NCBI
  39. Hussain M. Molecular dynamics simulations of glycyrrhizic acid aggregates as drug-carriers for paclitaxel. Curr Drug Deliv 2019;16(7):618-627 View Article PubMed/NCBI
  40. Tucker IM, Burley A, Petkova RE, Hosking SL, Penfold J, Thomas RK, et al. Adsorption and self-assembly properties of the plant based biosurfactant, Glycyrrhizic acid. J Colloid Interface Sci 2021;598:444-454 View Article PubMed/NCBI
  41. Zhao X, Zhang H, Gao Y, Lin Y, Hu J. A simple injectable moldable hydrogel assembled from natural glycyrrhizic acid with inherent antibacterial activity. ACS Appl Bio Mater 2020;3(1):648-653 View Article PubMed/NCBI
  42. You G, Feng T, Zhang G, Chen M, Liu F, Sun L, et al. Preparation, optimization, characterization and in vitro release of baicalein-solubilizing glycyrrhizic acid nano-micelles. Int J Pharm 2021;601:120546 View Article PubMed/NCBI
  43. Bag BG, Majumdar R. Self-assembly of a renewable nano-sized triterpenoid 18β-glycyrrhetinic acid. RSC Adv 2012;2:8623-8626 View Article PubMed/NCBI
  44. Wu J, Lu J, Hu J, Gao Y, Ma Q, Ju Y. Self-assembly of sodium glycyrrhetinate into a hydrogel: characterisation and properties. RSC Adv 2013;3:24906-24909 View Article PubMed/NCBI
  45. Wang J, Zhao H, Qiao W, Cheng J, Han Y, Yang X. Nanomedicine-cum-carrier by co-assembly of natural small products for synergistic enhanced antitumor with tissues protective actions. ACS Appl Mater Interfaces 2020;12(38):42537-42550 View Article PubMed/NCBI
  46. Ratan ZA, Haidere MF, Hong YH, Park SH, Lee JO, Lee J, et al. Pharmacological potential of ginseng and its major component ginsenosides. J Ginseng Res 2021;45(2):199-210 View Article PubMed/NCBI
  47. Dai X, Shi X, Wang Y, Qiao Y. Solubilization of saikosaponin a by ginsenoside Ro biosurfactant in aqueous solution: mesoscopic simulation. J Colloid Interface Sci 2012;384(1):73-80 View Article PubMed/NCBI
  48. Dai X, Shi X, Yin Q, Ding H, Qiao Y. Multiscale study on the interaction mechanism between ginsenoside biosurfactant and saikosaponin a. J Colloid Interface Sci 2013;396:165-172 View Article PubMed/NCBI
  49. Dai X, Shi X, Ding H, Yin Q, Qiao Y. Dissipative particle dynamics simulation of ginsenoside ro vesicular solubilization systems. J Comput Theor Nanosci 2014;11:2046-2054 View Article PubMed/NCBI
  50. Xiao Y, Liu J, Guo M, Zhou H, Jin J, Liu J, et al. Synergistic combination chemotherapy using carrier-free celastrol and doxorubicin nanocrystals for overcoming drug resistance. Nanoscale 2018;10(26):12639-12649 View Article PubMed/NCBI
  51. Dai X, Ding H, Yin Q, Wan G, Shi X, Qiao Y. Dissipative particle dynamics study on self-assembled platycodin structures: the potential biocarriers for drug delivery. J Mol Graph Model 2015;57:20-26 View Article PubMed/NCBI
  52. Zhi K, Zhao H, Yang X, Zhang H, Wang J, Wang J, et al. Natural product gelators and a general method for obtaining them from organisms. Nanoscale 2018;10(8):3639-3643 View Article PubMed/NCBI
  53. Zhi K, Wang J, Zhao H, Yang X. Self-assembled small molecule natural product gel for drug delivery: a breakthrough in new application of small molecule natural products. Acta Pharm Sin B 2020;10(5):913-927 View Article PubMed/NCBI
  54. Yang X, Ma C, Chen Z, Liu J, Liu F, Xie R, et al. Single small molecule-assembled nanoparticles mediate efficient oral drug delivery. Nano Res 2019;12:2468-2476 View Article PubMed/NCBI
  55. Ledeţi I, Avram Ş, Bercean V, Vlase G, Vlase T, Ledeţi A, et al. Solid-state characterization and biological activity of betulonic acid derivatives. Molecules 2015;20(12):22691-22702 View Article PubMed/NCBI
  56. Wang J, Qiao W, Zhao H, Yang X. Paclitaxel and betulonic acid synergistically enhance antitumor efficacy by forming co-assembled nanoparticles. Biochem Pharmacol 2020;182:114232 View Article PubMed/NCBI
  57. Zhi K, Wang J. Retraction: A self-assembled supramolecular natural product gel from liquidambaric acid in traditional Chinese medicine with inherent anti-inflammatory activity for drug delivery. J Mater Chem B 2020;8(48):11109 View Article PubMed/NCBI
  58. Folmer BM. Sterol surfactants: from synthesis to applications. Adv Colloid Interface Sci 2003;103(2):99-119 View Article PubMed/NCBI
  59. Cheng J, Zhao H, Yao L, Li Y, Qi B, Wang J, et al. Simple and multifunctional natural self-assembled sterols with anticancer activity-mediated supramolecular photosensitizers for enhanced antitumor photodynamic therapy. ACS Appl Mater Interfaces 2019;11(33):29498-29511 View Article PubMed/NCBI
  60. Debnath B, Singh WS, Das M, Goswami S, Singh MK, Maiti D, et al. Role of plant alkaloids on human health: A review of biological activities. Mater Today Chem 2018;9:56-72 View Article PubMed/NCBI
  61. Bribi N. Pharmacological activity of alkaloids: a review. Asian J Bot 2018;1:1-6 View Article PubMed/NCBI
  62. Song D, Hao J, Fan D. Biological properties and clinical applications of berberine. Front Med 2020;14(5):564-582 View Article PubMed/NCBI
  63. Chen M, Wang P, Li T, Li L, Li J, Bai H, et al. Comprehensive analysis of Huanglian Jiedu decoction: Revealing the presence of a self-assembled phytochemical complex in its naturally-occurring precipitate. J Pharm Biomed Anal 2021;195:113820 View Article PubMed/NCBI
  64. Zhang C, Zhao R, Yan W, Wang H, Jia M, Zhu N, et al. Compositions, formation mechanism, and neuroprotective effect of compound precipitation from the traditional chinese prescription Huang-Lian-Jie-Du-Tang. Molecules 2016;21(8):E1094 View Article PubMed/NCBI
  65. Wang H, Li T, Xiang H, Zhang X, Fang K, Wu G, et al. Origin and formation mechanism investigation of compound precipitation from the traditional Chinese prescription Huang-Lian-Jie-Du-Tang by isothermal titration calorimetry. Molecules 2017;22(9):E1456 View Article PubMed/NCBI
  66. Li T, Wang P, Guo W, Huang X, Tian X, Wu G, et al. Natural berberine-based chinese herb medicine assembled nanostructures with modified antibacterial application. ACS Nano 2019;13(6):6770-6781 View Article PubMed/NCBI
  67. Li L, Cui H, Li T, Qi J, Chen H, Gao F, et al. Synergistic effect of berberine-based Chinese medicine assembled nanostructures on diarrhea-predominant irritable bowel syndrome In Vivo. Front Pharmacol 2020;11:1210 View Article PubMed/NCBI
  68. Huang X, Wang P, Li T, Tian X, Guo W, Xu B, et al. Self-assemblies based on traditional medicine berberine and cinnamic acid for adhesion-induced inhibition multidrug-resistant Staphylococcus aureus. ACS Appl Mater Interfaces 2020;12(1):227-237 View Article PubMed/NCBI
  69. Han N, Huang X, Tian X, Li T, Liu X, Li W, et al. Self-assembled nanoparticles of natural phytochemicals (berberine and 3,4,5-methoxycinnamic acid) originated from traditional chinese medicine for inhibiting multidrug-resistant staphylococcus aureus. Curr Drug Deliv 2021;18(7):914-921 View Article PubMed/NCBI
  70. Tian X, Wang P, Li T, Huang X, Guo W, Yang Y, et al. Self-assembled natural phytochemicals for synergistically antibacterial application from the enlightenment of traditional Chinese medicine combination. Acta Pharm Sin B 2020;10(9):1784-1795 View Article PubMed/NCBI
  71. Gökmen MR, Lord GM. Aristolochic acid nephropathy. BMJ 2012;344:e4000 View Article PubMed/NCBI
  72. Wang P, Guo W, Huang G, Zhen J, Li Y, Li T, et al. Berberine-based heterogeneous linear supramolecules neutralized the acute nephrotoxicity of aristolochic acid by the self-assembly strategy. ACS Appl Mater Interfaces 2021;13(28):32729-32742 View Article PubMed/NCBI
  73. Shen Y, Zou Y, Chen X, Li P, Rao Y, Yang X, et al. Antibacterial self-assembled nanodrugs composed of berberine derivatives and rhamnolipids against Helicobacter pylori. J Control Release 2020;328:575-586 View Article PubMed/NCBI
  74. Wang F, Porter M, Konstantopoulos A, Zhang P, Cui H. Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy. J Control Release 2017;267:100-118 View Article PubMed/NCBI
  75. Pei Q, Hu X, Zhou J, Liu S, Xie Z. Glutathione-responsive paclitaxel dimer nanovesicles with high drug content. Biomater Sci 2017;5(8):1517-1521 View Article PubMed/NCBI
  76. Cheng Y, Ji Y. Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment with enhanced cytotoxicity. J Control Release 2020;318:38-49 View Article PubMed/NCBI
  77. Zhang C, Long L, Xiong Y, Wang C, Peng C, Yuan Y, et al. Facile engineering of indomethacin-induced paclitaxel nanocrystal aggregates as carrier-free nanomedicine with improved synergetic antitumor activity. ACS Appl Mater Interfaces 2019;11(10):9872-9883 View Article PubMed/NCBI
  78. Chen X, Xie B, Huang L, Wan J, Wang Y, Shi X, et al. Quantitative self-assembly of pure drug cocktails as injectable nanomedicines for synergistic drug delivery and cancer therapy. Theranostics 2021;11(12):5713-5727 View Article PubMed/NCBI
  79. Ghanbari-Movahed M, Kaceli T, Mondal A, Farzaei MH, Bishayee A. Recent advances in improved anticancer efficacies of camptothecin nano-formulations: a systematic review. Biomedicines 2021;9(5):480 View Article PubMed/NCBI
  80. Qin SY, Peng MY, Rong L, Li B, Wang SB, Cheng SX, et al. Self-defensive nano-assemblies from camptothecin-based antitumor drugs. Regen Biomater 2015;2(3):159-166 View Article PubMed/NCBI
  81. Zhao Y, Chen F, Pan Y, Li Z, Xue X, Okeke CI, et al. Nanodrug formed by coassembly of dual anticancer drugs to inhibit cancer cell drug resistance. ACS Appl Mater Interfaces 2015;7(34):19295-19305 View Article PubMed/NCBI
  82. Chen F, Zhao Y, Pan Y, Xue X, Zhang X, Kumar A, et al. Synergistically enhanced therapeutic effect of a carrier-free HCPT/DOX nanodrug on breast cancer cells through improved cellular drug accumulation. Mol Pharm 2015;12(7):2237-2244 View Article PubMed/NCBI
  83. Giordano A, Tommonaro G. Curcumin and cancer. Nutrients 2019;11(10):E2376 View Article PubMed/NCBI
  84. Xiao H, Guo Y, Liu H, Liu Y, Wang Y, Li C, et al. Structure-based design of charge-conversional drug self-delivery systems for better targeted cancer therapy. Biomaterials 2020;232:119701 View Article PubMed/NCBI
  85. Li J, Li X, Liu P. Doxorubicin-doxorubicin conjugate prodrug as drug self-delivery system for intracellular pH-triggered slow release. Colloids Surf B Biointerfaces 2020;185:110608 View Article PubMed/NCBI
  86. Xiong H, Wang Z, Wang C, Yao J. Transforming complexity to simplicity: protein-like nanotransformer for improving tumor drug delivery programmatically. Nano Lett 2020;20(3):1781-1790 View Article PubMed/NCBI
  87. Zheng J, Fan R, Wu H, Yao H, Yan Y, Liu J, et al. Directed self-assembly of herbal small molecules into sustained release hydrogels for treating neural inflammation. Nat Commun 2019;10(1):1604 View Article PubMed/NCBI
  88. Liu Y, Zhao L, Shen G, Chang R, Zhang Y, Yan X. Coordination self-assembly of natural flavonoids into robust nanoparticles for enhanced in vitro chemo and photothermal cancer therapy. Colloid Surface A 2020;598:124805 View Article PubMed/NCBI
  89. Liao H, Zhao S, Wang H, Liu Y, Zhang Y, Sun G. Self-assembly of retinoid nanoparticles for melanoma therapy. Int J Nanomedicine 2019;14:7963-7973 View Article PubMed/NCBI

Copyright © 2022 Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • © 2024 Xia & He Publishing Inc.
  • Total visits : 2755744
  • Visits today : 415